Albupad
French tech company | Builders Republic
About
Maker of a patented biomaterial platform based on stabilized human albumin protein for slow release of biologic drugs — injectable or implantable formulations that gradually dissolve under the skin to space out dosing for chronic-disease and cancer therapies.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2024
- City
- STRASBOURG
- Region
- Grand Est
- Tracked rounds
- 1
- Amount raised
- 1.3 M€ raised since 2020
Funding rounds
- Seed — 2026